Show simple item record

dc.contributor.authorde la Campa, Adela G 
dc.contributor.authorFerrandiz-Avellano, Maria-Jose 
dc.contributor.authorTubau, Fe
dc.contributor.authorPallarés, Román
dc.contributor.authorManresa, Federico
dc.contributor.authorLiñares, Josefina
dc.date.accessioned2019-08-13T12:07:13Z
dc.date.available2019-08-13T12:07:13Z
dc.date.issued2003-04
dc.identifier.citationAntimicrob Agents Chemother. 2003 Apr;47(4):1419-22.es_ES
dc.identifier.issn0066-4804es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/8235
dc.description.abstractFive Spain(9V-3) Streptococcus pneumoniae strains were isolated from a patient with bronchiectasis who had received long-term ciprofloxacin therapy. One ciprofloxacin-susceptible strain was isolated before treatment, and four ciprofloxacin-resistant strains were isolated during treatment. The resistant strains were derived from the susceptible strain either by a parC mutation (low-level resistance) or by parC and gyrA mutations (high-level resistance). This study shows that ciprofloxacin therapy in a patient colonized by susceptible S. pneumoniae may select fluoroquinolone-resistant mutants.es_ES
dc.description.sponsorshipWe thank A. Fenoll, Spanish Pneumococcus Reference Laboratory (Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, Madrid), for checking serotypes. We thank M. A. Dominguez for performing the PFGE analysis and critically reading the manuscript. This work was supported by grants 00/0258 and 01/1267 from the Fondo de Investigación Sanitaria and by grant BIO2002-01398 from the Ministerio de Ciencia y Tecnología.es_ES
dc.language.isoenges_ES
dc.publisherAmerican Society for Microbiologyes_ES
dc.relation.isversionofPreprintes_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/*
dc.subject.meshAnti-Infective Agents es_ES
dc.subject.meshBronchiectasis es_ES
dc.subject.meshCiprofloxacin es_ES
dc.subject.meshDrug Resistance, Bacterial es_ES
dc.subject.meshHumans es_ES
dc.subject.meshMale es_ES
dc.subject.meshMiddle Aged es_ES
dc.subject.meshStreptococcus pneumoniae es_ES
dc.subject.meshMutation es_ES
dc.titleGenetic characterization of fluoroquinolone-resistant Streptococcus pneumoniae strains isolated during ciprofloxacin therapy from a patient with bronchiectasises_ES
dc.typeArtículoes_ES
dc.rights.licenseAtribución-NoComercial-CompartirIgual 4.0 Internacional*
dc.identifier.pubmedID12654682es_ES
dc.format.volume47es_ES
dc.format.number4es_ES
dc.format.page1419-22es_ES
dc.identifier.doi10.1128/aac.47.4.1419-1422.2003es_ES
dc.contributor.funderFondo de Investigaciones Sanitarias
dc.contributor.funderMinisterio de Ciencia y Tecnología (España)
dc.relation.publisherversionhttps://doi.org/10.1128/AAC.47.4.1419-1422.2003es_ES
dc.identifier.journalAntimicrobial agents and chemotherapyes_ES
dc.repisalud.centroISCIII::Centro Nacional de Microbiologíaes_ES
dc.repisalud.institucionISCIIIes_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/00/0258es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/01/1267es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/BIO2002-01398es_ES
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES


Files in this item

Acceso Abierto
Thumbnail
Acceso Abierto
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Atribución-NoComercial-CompartirIgual 4.0 Internacional
This item is licensed under a: Atribución-NoComercial-CompartirIgual 4.0 Internacional